Health
SEROLOGICAL RESPONSES AFTER SARS‐COV‐2 VACCINATION FIRST DOSE IN PATIENTS WITH LYMPHOID MALIGNANCY: FIRST INTERIM ANALYSIS OF THE UK PROSECO STUDY – Wiley
Click on the article title to read more.
Introduction: COVID-19 is thought to be more frequent and severe in patients with cancer. Lymphoma patients may be especially vulnerable, due to the immunodeficiency and immune dysregulation caused by the lymphoma itself and the antitumor treatments. This…
Continue Reading
-
General16 hours agoAustralian celebrity chef Peter Russell-Clarke dies aged 89
-
Noosa News16 hours agoWoman airlifted to Brisbane hospital after big cat mauling at south-east Queensland zoo near Toowoomba
-
Business22 hours agoInvested $10,000 in Westpac shares 2 years ago? Guess how much you’ve already banked!
-
Noosa News15 hours agoUnvaccinated horse dies from Hendra virus as Queensland records first case in three years